Converting to a Common Data Model: What is Lost in Translation? Peter R. Rijnbeek Commentary 04 September 2014 Pages: 893 - 896
Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications Alfonso E. BelloRobert J. Holt Current Opinion Open access 31 July 2014 Pages: 897 - 902
Pharmacotherapy of Type 2 Diabetes Mellitus: An Update on Drug–Drug Interactions Muhammad AminNaeti Suksomboon Review Article 24 September 2014 Pages: 903 - 919
Side Effects of Cytokines Approved for Therapy Brian A. Baldo Review Article 01 October 2014 Pages: 921 - 943
Fidelity Assessment of a Clinical Practice Research Datalink Conversion to the OMOP Common Data Model Amy MatchoPatrick RyanChristian Reich Original Research Article Open access 04 September 2014 Pages: 945 - 959
Safety Profile of Biological Medicines as Compared with Non-Biologicals: An Analysis of the Italian Spontaneous Reporting System Database Paola M. CutroneoValentina IsgròGianluca Trifirò Original Research Article 26 September 2014 Pages: 961 - 970
Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS) Keith B. HoffmanAndrea R. DemakasColin B. Erdman Original Research Article Open access 26 September 2014 Pages: 971 - 980
Relevance of Foreign Alerts and Newsletters for the Medication Errors Reporting Programme in The Netherlands: An Explorative Retrospective Study Ka-Chun CheungPatricia M. L. A. van den BemtPeter A. G. M. De Smet Original Research Article 26 September 2014 Pages: 981 - 987
Erratum to: Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study Robert J. CampbellChaim M. BellSudeep S. Gill Erratum 22 August 2014 Pages: 989 - 989